ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,969Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 617

$515K Total Retail Price of All Prescriptions

Rank: 91 out of 617

390 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 390 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,080 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 568 564 1 1
SIMVASTATIN 350 339 2 2
MELOXICAM 292 276 3 24
OMEPRAZOLE 285 270 4 3
METOPROLOL SUCCINATE 281 269 5 12
WARFARIN SODIUM 280 256 6 7
LISINOPRIL 243 218 7 5
FUROSEMIDE 241 219 8 4
HYDROCHLOROTHIAZIDE 194 181 9 13
CARVEDILOL 187 161 10 19
METFORMIN HCL 184 156 11 9
TRAMADOL HCL 181 120 12 15
GABAPENTIN 180 157 13 16
PANTOPRAZOLE SODIUM 175 168 14 37
AMLODIPINE BESYLATE 171 154 15 6
ATORVASTATIN CALCIUM 156 156 16 14
DIGOXIN 153 153 17 48
POLYETHYLENE GLYCOL 3350 143 130 18 32
CITALOPRAM HBR 139 128 19 18
ENALAPRIL MALEATE 131 105 20 34
NAMENDA 127 127 21 35
SPIRONOLACTONE 119 107 22 42
HYDROCODONE-ACETAMINOPHEN 118 100 S3 23 8
GLIMEPIRIDE 115 103 24 33
ALLOPURINOL 110 108 25 27
CRESTOR 109 95 26 28
LOSARTAN POTASSIUM 109 109 26 22
VERAPAMIL ER 99 99 28 90
NEXIUM 99 99 28 43
POTASSIUM CHLORIDE 98 98 30 10
AMLODIPINE BESYLATE-BENAZEPRIL 92 71 31 80
VYTORIN 91 79 32 160
BYSTOLIC 90 90 33 64
CELEBREX 85 85 34 63
PREMARIN 85 85 R 34 108
ZOLPIDEM TARTRATE 82 82 36 23
ROPINIROLE HCL 81 71 37 66
DILTIAZEM 24HR CD 80 80 38 117
TORSEMIDE 79 57 39 110
BENAZEPRIL HCL 78 73 40 44
ALENDRONATE SODIUM 76 76 41 25
FAMOTIDINE 75 75 42 54
FLUOXETINE HCL 74 52 43 73
PREDNISONE 74 74 43 31
ADVAIR DISKUS 73 72 45 38
DIOVAN HCT 73 73 45 97
CEPHALEXIN 70 68 47 68
METOCLOPRAMIDE HCL 70 70 47 125
RANITIDINE HCL 69 46 49 40
DOXAZOSIN MESYLATE 65 65 50 79
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63 51 46
METOPROLOL TARTRATE 62 57 52 11
ACTOS 60 46 53 85
ATENOLOL 58 58 54 17
DONEPEZIL HCL 58 58 54 30
FENTANYL 56 56 S2 56 45
DIOVAN 55 55 57 41
SERTRALINE HCL 54 54 58 20
GLYBURIDE-METFORMIN HCL 51 42 R 59 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.